DE602004026466D1 - Neue mittel zur prävention von leishmaniose - Google Patents

Neue mittel zur prävention von leishmaniose

Info

Publication number
DE602004026466D1
DE602004026466D1 DE602004026466T DE602004026466T DE602004026466D1 DE 602004026466 D1 DE602004026466 D1 DE 602004026466D1 DE 602004026466 T DE602004026466 T DE 602004026466T DE 602004026466 T DE602004026466 T DE 602004026466T DE 602004026466 D1 DE602004026466 D1 DE 602004026466D1
Authority
DE
Germany
Prior art keywords
seq
coding
leishmaniose
prevention
leishmania
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004026466T
Other languages
English (en)
Inventor
Jean-Loup Lemesre
Mireille Cavaleyra
Denis Sereno
Philippe Holzmuller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut de Recherche pour le Developpement IRD
Original Assignee
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0313555A external-priority patent/FR2862313B1/fr
Application filed by Institut de Recherche pour le Developpement IRD filed Critical Institut de Recherche pour le Developpement IRD
Publication of DE602004026466D1 publication Critical patent/DE602004026466D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DE602004026466T 2003-11-19 2004-11-19 Neue mittel zur prävention von leishmaniose Active DE602004026466D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0313555A FR2862313B1 (fr) 2003-11-19 2003-11-19 Nouveaux moyens pour la prevention des leishmanioses
FR0407010A FR2863272B1 (fr) 2003-11-19 2004-06-25 Nouveaux moyens pour la prevention des leishmanioses
PCT/FR2004/002955 WO2005051989A2 (fr) 2003-11-19 2004-11-19 Nouveaux moyens pour la prévention des leishmanioses

Publications (1)

Publication Number Publication Date
DE602004026466D1 true DE602004026466D1 (de) 2010-05-20

Family

ID=34593697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004026466T Active DE602004026466D1 (de) 2003-11-19 2004-11-19 Neue mittel zur prävention von leishmaniose

Country Status (11)

Country Link
US (2) US8574598B2 (de)
EP (1) EP1685156B1 (de)
AT (1) ATE463507T1 (de)
AU (1) AU2004293211B2 (de)
BR (1) BRPI0416736B8 (de)
CA (1) CA2546326C (de)
DE (1) DE602004026466D1 (de)
ES (1) ES2345824T3 (de)
FR (1) FR2863272B1 (de)
PT (1) PT1685156E (de)
WO (1) WO2005051989A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863272B1 (fr) 2003-11-19 2006-06-09 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
FR2881752B1 (fr) * 2005-02-10 2009-07-31 Inst Rech Pour Le Dev I R D Et Moyens pour l'obtention de promastigotes de leishmanies avirulents, promastigotes obtenus et leurs applications
FR2932802B1 (fr) * 2008-06-19 2010-08-20 Oridan Inc Peptide de synthese non natif cyclise et complexe de peptides comprenant ledit peptide cyclise, destine a induire et a caracteriser la prevention ou le traitement d'affections chez les mammiferes
FR2960550A1 (fr) 2010-05-26 2011-12-02 Inst Rech R Pour Le Dev Ird Moyens pour la production transitoire dans les plantes de proteines recombinantes utilisables notamment en prophylaxie et en therapeutique
FR3014103B1 (fr) * 2013-11-29 2019-08-16 Institut De Recherche Pour Le Developpement (Ird) Composition vaccinale pour la prevention et/ou le traitement de leishmanioses, peptides immunogenes et procede d'obtention
BR112022010228A2 (pt) * 2019-12-17 2022-09-06 Us Health Vacinas de parasita de leishmania viva atenuada com características de segurança aumentadas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2705358B1 (fr) * 1993-05-13 1995-08-04 Orstom Procédé de culture in vitro de différents stades de parasites tissulaires, stades parasitaires obtenus et applications biologiques.
US20020169285A1 (en) * 1995-09-22 2002-11-14 Reed Steven G. Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2169995B1 (es) * 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
FR2863272B1 (fr) 2003-11-19 2006-06-09 Inst Rech Developpement Ird Nouveaux moyens pour la prevention des leishmanioses
FR2881752B1 (fr) * 2005-02-10 2009-07-31 Inst Rech Pour Le Dev I R D Et Moyens pour l'obtention de promastigotes de leishmanies avirulents, promastigotes obtenus et leurs applications

Also Published As

Publication number Publication date
US20140193452A1 (en) 2014-07-10
ATE463507T1 (de) 2010-04-15
WO2005051989A2 (fr) 2005-06-09
FR2863272A1 (fr) 2005-06-10
AU2004293211A1 (en) 2005-06-09
CA2546326C (fr) 2013-08-27
FR2863272B1 (fr) 2006-06-09
WO2005051989A3 (fr) 2005-09-29
AU2004293211B2 (en) 2011-04-21
EP1685156B1 (de) 2010-04-07
EP1685156A2 (de) 2006-08-02
BRPI0416736B1 (pt) 2019-05-21
BRPI0416736B8 (pt) 2021-05-25
BRPI0416736A (pt) 2007-01-16
ES2345824T3 (es) 2010-10-04
US20080026467A1 (en) 2008-01-31
PT1685156E (pt) 2010-05-31
CA2546326A1 (fr) 2005-06-09
US8574598B2 (en) 2013-11-05

Similar Documents

Publication Publication Date Title
DK2071028T3 (da) HLA-DR-bindende antigenpeptid afledt af WT1
WO2003029401A8 (en) Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE602004026466D1 (de) Neue mittel zur prävention von leishmaniose
WO2002026947A3 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2009083968A8 (en) Novel protein
WO2002016566A3 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2005105838A3 (en) Ion channel
WO2002050286A3 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
ATE427355T1 (de) Menschliche alpha2-delta4-calciumkanal- untereinheit codierende cdna
WO2001081413A3 (en) Isolated human transporter proteins, nucleic acids and uses thereof
WO2002046406A3 (en) Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
WO2002077190A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002072765A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2003074675A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002022678A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002059326A3 (en) Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
WO2002024910A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
WO2002042436A3 (en) Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
TH77072B (th) กรดนิวคลีอิกที่ทำรหัสแอนติเจน ตัวเชื่อมโยง 230 kDa จากสปอโรโซไอต์/มีโรโซไอต์ ของ Eimeria maxima, และการนำไปใช้
WO2002079494A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002074976A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002064626A3 (en) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
ATE409747T1 (de) Mit wt1 interagierendes protein, wtip
WO2001088136A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition